World Innovation Summit for Health Announces Dates for 2024 Event and Strategic Partnership with WHO

December 06, 2023 02:00 PM EST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 World Innovation Summit for Health Announces Dates for 2024 Event and Strategic Partnership with WHO
Image source: Kalkine Media

Health leaders to prepare report on the protection of health in armed conflict.

DOHA, Qatar, Dec. 7, 2023 /PRNewswire/ -- The World Innovation Summit for Health (WISH), an initiative of Qatar Foundation for Education, Science and Community Development (QF), announced the WISH 2024 summit will take place in Doha on November 13 and 14, 2024.

Dr Tedros Adhanom Ghebreyesus (seated left) , Director General, WHO, and Sultana Afdhal, CEO, WISH, sign a collaboration agreement at Qatar Foundation’s headquarters, witnessed by Her Excellency Dr Hanan Mohamed Al Kuwari (top right), Minister of Public Health in Qatar, and representatives of WHO.
Dr Tedros Adhanom Ghebreyesus (seated left) , Director General, WHO, and Sultana Afdhal, CEO, WISH, sign a collaboration agreement at Qatar Foundation’s headquarters, witnessed by Her Excellency Dr Hanan Mohamed Al Kuwari (top right), Minister of Public Health in Qatar, and representatives of WHO.

Across two days, more than 2,000 health policy makers, innovators, researchers and practitioners will convene in Qatar to look for innovative solutions to some of the world's biggest health challenges.

WISH 2024 will be the seventh edition of WISH – an event now firmly established as a vital feature on the global health calendar.

Following high-level discussions between Her Highness Sheikha Moza bint Nasser, Chairperson of QF, and Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), WISH will be entering into a strategic partnership with the WHO in the lead up to WISH 2024, formalizing an ongoing relationship between two over recent years.

Central to the partnership will be three WHO-led collaborative research projects, generating evidence-based reports for in-depth discussion at event.

Additionally, local and international partners will work with WISH to develop reports for the summit on a range of issues in areas such as health systems, ethics, physical health, and mental health. WISH 2024 will continue to emphasize the need for regional perspectives on global health.

WISH CEO Sultana Afdhal was joined by Dr. Tedros at a ceremony to sign a collaboration agreement between WISH and WHO on December 4th.  

The agreement signing was witnessed by Her Excellency Dr Hanan Mohamed Al Kuwari, who, in addition to being Minister of Public Health for the State of Qatar, is the current Chair of the World Health Organization's Executive Board. The Ministry is a strategic partner of WISH, having supported the summit since the first edition ten years ago.

Sultana Afdhal said: "We are delighted to share that we will be back with WISH 2024 next November; we remain committed to creating a platform where evidence-based research can inform global health practices. It is an honor to welcome Dr. Tedros to the WISH 2024 launch, to share news of our strategic partnership, and to share our vision for a healthier, more equitable world."

Dr Tedros expressed his appreciation to Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation, for the new partnership and said: "Our expanding collaboration with WISH builds on a track record of impact and will further demonstrate our joint resolve to tackle pressing global health issues, including tuberculosis, palliative care and protecting health in armed conflict. We look forward to contributing to the evidence base and are very much committed to the partnership."

More WISH 2024 themes and speakers will be announced over the coming months. Those wishing to register their interest to attend the conference can do so via the WISH website: wish.org.qa

For media inquiries, please contact: Sarah Fouad, on [email protected], +974 66099846

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Canadian AI All-Stars: Unveiling the Top Stocks for 2024

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.